Phase II Trial of Neoadjuvant and Adjuvant Anti-PD-1 Antibody Toripalimab Combined With CCRT in NPC Patients
Clinical trial NCT03925090 · UNKNOWN
Trial details
- NCT number
- NCT03925090
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-08
- Primary completion
- 2021-12-06
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.